Biological Information
Background Information:
Evaluation of two compounds in any BioMAP system, individually and in combination. The StroHT29 system is comprised of dermal fibroblasts, the HT-29 colorectal adenocarcinoma cell line, and peripheral blood mononuclear cells. This stromal tumor microenvironment (TME) model is stimulated via the T cell receptor for 48-hrs to recapitulate the activation of tumor infiltrating immune cells in the context of an immunosuppressive cancer cell line and normal host stromal tissue. These conditions model the host stromal-immune-tumor microenvironment by capturing the complex interactions between tumor cells, the host stromal network, and infiltrating immune cells recruited into the tumor mass. Biomarker readouts capture impacts on translationally relevant immune, matrix remodeling, and inflammation-related intratumoral responses.
Organism:
Human
Assay Information
Assay Type:
Functional
Assay Sub Type:
Cell Based
Testing Information
Test Concentration / Dose:
Two test agents profiled alone at four concentrations, and in combination in a four-by-four matrix, in triplicate.
Test Sample Requirements:
For Small Molecules: 350uL of a 1000X stock based on the top concentration being tested & standard 3-fold dilutions per system and per Combo. For Biologics: 3.5mL of a 100X stock in PBS or water, based on the top concentration being tested & standard 3-fold dilutions per system and per Combo
Turnaround Time
Standard:
40 Business Days
Clinical Relevance
Therapeutic Area:
Oncology/Immuno-Oncology
Additional Information
Brand:
BioMAP
Testing Location:
USA - St Charles, MO
RELATED SOLUTIONS